TritonPoint Wealth’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$565K Hold
2,280
0.06% 166
2026
Q1
$458K Hold
2,280
0.05% 184
2025
Q4
$471K Hold
2,280
0.05% 181
2025
Q3
$409K Hold
2,280
0.04% 247
2025
Q2
$368K Hold
2,280
0.03% 256
2025
Q1
$388K Hold
2,280
0.04% 243
2024
Q4
$379K Hold
2,280
0.03% 242
2024
Q3
$390K Sell
2,280
-460
-17% -$76.1K 0.04% 242
2024
Q2
$422K Sell
2,740
-9,178
-77% -$1.38M 0.04% 223
2024
Q1
$1.88M Sell
11,918
-877
-7% -$134K 0.2% 109
2023
Q4
$2.02M Buy
+12,795
New +$1.84M 0.2% 110

Other funds holding FBT

TritonPoint Wealth's FBT Position: Q2 2026 in Review

TritonPoint Wealth held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 2,280 shares worth $565K. The position accounts for 0.06% of the portfolio, ranked #166.

TritonPoint Wealth first reported a position in FBT in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.02M in Q4 2023. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • TritonPoint Wealth held 2,280 shares of First Trust NYSE Arca Biotechnology Index Fund worth $565K as of Q2 2026.
  • TritonPoint Wealth left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.06% of TritonPoint Wealth's portfolio in Q2 2026, its #166 holding.
  • TritonPoint Wealth first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 11 quarters since.
  • TritonPoint Wealth's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.02M in Q4 2023.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on TritonPoint Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.